SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-24-000409
Filing Date
2024-06-28
Accepted
2024-06-28 16:21:42
Documents
1
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4043
  Complete submission text file 0000904454-24-000409.txt   5507
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 11058BP
Business Address
Abi-Saab Walid (Reporting) CIK: 0001985973 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 241086049